The synergy between combinatorial chemistry and high-throughput screening.

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Chemical Biology

Background:

• Combinatorial chemistry, especially large library approaches, was expected to accelerate drug discovery.
• This potential has not been fully realized in building compound collections for pharmaceutical and biotechnology companies.

Purpose of the Study:

• To review the strengths of large library combinatorial chemistry for lead discovery.
• To discuss challenges and emerging concepts from high-throughput screening and fragment-based drug design.
• To examine the influence of these methods on combinatorial library design and data interpretation.

Main Methods:

• Literature review focusing on large library combinatorial chemistry.
• Analysis of strengths in generating lead discovery molecules.
• Discussion of challenges and integration with high-throughput screening and fragment-based drug design.

Main Results:

• Large library combinatorial chemistry provides robust structure-activity relationships for hit series.
• Challenges exist in fully utilizing this approach for compound collection development.
• High-throughput screening and fragment-based drug design influence library design and data analysis.

Conclusions:

• Large library combinatorial chemistry remains a valuable tool for lead discovery despite utilization challenges.
• Integrating insights from high-throughput screening and fragment-based drug design is crucial for optimizing combinatorial library strategies.
• Further development is needed to fully leverage combinatorial chemistry in drug discovery pipelines.